Clean Sweep on Options Plays & More

Across the Board Options Sweep: 

Yesterday was another banner day for big name earnings reporters, and we got in on the fun by signaling three sets of fresh options ideas in our premarket report.

We were signaling our interest in the UPS Weekly $207.50-212.50 Calls, the FB Weekly $325-332.50 Calls, and the LMT Weekly $360-345 Puts. Each one turned out to be a very solid play with sizable intraday gain opportunities on the table, but the Lockheed short ended up being the runner of the highest magnitude as the stock took an absolute bath.

Here are the figures on the daily ranges and total possible profits on those shrewd ideas:

UPS Weekly $207.50-212.50 Calls
$207.50:
 8.19-13.20 (+145%)
$210: 5.78-11.50 (+186%)
$212.50: 1.20-2.94 (+145%)
_____

FB Weekly $325-332.50 Calls
$325:
 1.33-2.46 (+85%)
$327.50: 1.05-1.91 (+82%)
$330: .85-1.54 (+81%)
$332.50: .70-1.26 (+80%)
_____

LMT Weekly $360-345 Puts
$360: 11.72-33.80 (+188%)
$355: 8.15-27.90 (+242%)
$350: 5.65-23.70 (+319%)
$345: 3.70-19.20 (+419%)
_____

Fresh Options Ideas:
BA Weekly $207.50-212.50 Calls
MCD Weekly $240-242.50 Calls
MSFT Weekly $312.50-315 Calls 


Meten Holding Group, Inc. METX – Recap: 

We also wanted to provide a brief recap on the performance of METX, which we highlighted in yesterday morning’s extended watchlist. We had just been mentioning how it’s important to peruse all of our plays and not just our features.

METX was nearly a fifty cent stock, running from .4845-.70 on the day, for a rise of 44% which is quite an impressive daily run for a stock in that price range.


Extended Watchlist:
KAVL, CXDC, PHUN, DGLY, GHSI, FAMI, LIGA, CZNI, BORK, MSGP

Torrent of Earnings Reporters Continues

Abbott Laboratories Inc. ABT – Options Recap:

ABT was among our targeted options plays in yesterday morning’s premarket report, and the company’s daily activity allowed for some solid options runs.

We were after the ABT Weekly $122-124 Calls in the wake of Abbott’s Q2 earnings drop, and thanks to a solid beat on both profits and and sales along with a lofty outlook for the remainder of the year, we saw the following multibag intraday moves from our selected target contract sets.

ABT Weekly $122-124 Calls

$122: 1.12-2.08 (+86%)
$123: .62-1.45 (+134%)
$124: .34-.85 (+150%)

We also had some NFLX Calls from Tuesday that underwent a massive dip and rip and posted the following numbers yesterday:

NFLX Weekly $635-640 Calls
$635:
 3.17-9.50 (+227%)
$640: 2.20-7.20 (+200%)
_____

Fresh Options Ideas: 

CSX Weekly $34-36 Calls
BX Weekly $130-133 Calls
T Weekly $25.50-26.50 Calls 


OTC Reviews:

We’ve also caught a couple of runners on the OTC Markets this week that we wanted to report on. We tagged initially BTZI on Monday, and LIGA yesterday morning, and they both yielded rapid results for us.

Bots Inc. BTZI

Initial Alert: Oct 18th
Range: .0795-.1749
Gained: +120%
_____

LIG Assets, Inc. LIGA

Initial Alert: Oct 20th
Range: .0069-.013
Gained: +88%


Extended Watchlist:
CBTC, GDET, BBBT, MWWC, WWDH, DWAC, HX, SESN, NXTP, JRJC, INND, BLDV, MGTI

Across-the-Board Options Sweep & More

A Solid Options Sweep:

We went all out in yesterday morning ‘s report with options ideas in four chains. We’re finally back into the swing of another earnings season and it feels great! We selected three off of the daily earnings calendar, and went with some SPY calls as well, and we were not disappointed in any regard.

All four of our designated targets saw appreciable intraday runs. Those were the SPY 10/20 $448-450 Calls, the NFLX Weekly $635-640 Calls, the TRV Weekly $155 Calls, and the STLD 11/19 $60-65 Calls. Some of the gains were rather modest, but they all went green for us, and here were their intraday ranges and total possible gains:

SPY 10/20 $448-450 Calls
$448: 
1.59-3.28 (+106%)
$449: 1.07-2.40 (+124%)
$450: .68-1.60 (+135%)
_____

NFLX Weekly $635-640 Calls
$635: 16.55-21.00 (+27%)
$640: 14.70-18.75 (+28%)
_____

TRV Weekly $155 Calls
$155: 4.15-5.50 (+33%)
_____

STLD 11/19 $60-65 Calls
$60: 3.20-5.70 (+78%)
$65: 1.15-2.62 (+95%)


Fresh Options Ideas: 
BIIB Weekly $270-275 Calls
ABT Weekly $122-124 Calls


Atea Pharmaceuticals, Inc. AVIR – Recap:

Also in yesterday morning’s report was a tag of AVIR, which gapped down hard in the the premarket and immediately set about filling that gap.

The stock traded in a daily range from a low of 10.76, cruised back to as high as 16.63 (+55%) and did so on massive volume to the tune of more than 34X the daily average. We will continue to track its activity under these interesting circumstances in upcoming sessions.


Extended Watchlist:
AITX, OZSC, SHMP, TONR, SEGI, MTRT, LIGA, RDUS, TRKA, CEI, LMDX

Blue Horseshoe Stocks: GIGL Explodes & More

Giggles N’ Hugs, Inc. GIGL

We were exceptionally pleased with the performance of GIGL after including it in Friday’s premarket report, and our timing really couldn’t have been any better. The stock had been trading sideways for months, without so much as a spike, yet it still broke out for a monstrous single-session move.

GIGL traded up from an early low of .0053, smashed through the penny barrier, and hurtled its way to an impressive high of .024. That worked out to an intraday push of 353% and it came on record volume.

For those reasons, we’ll certainly be ready to continue monitoring the activity in this play. We’ll of course allow for the possibility of some course correction, but the odds of seeing either a continued increase, or a dip-and-rip scenario, seem reasonably high at this point.


LIG Assets, Inc. LIGA

We also got a pretty good performance out of LIGA, which was another inclusion from Friday’s report. The move didn’t quite rise to the magnitude of the aforementioned stock, it did attain double-bagger status with a significant gain opportunity.

From a low of .001, we watched as LIGA shot to a high of .0022 inside of the first two hours of trading. That was good for quick gains of up to 120%    Perhaps just as importantly, the stock maintained more than half of its daily advance, so we’ll be keeping an eye peeled in sessions to come.


Merrimack Pharmaceuticals, Inc. MACK

We also want to draw attention to MACK this morning, a stock that we haven’t visited in quite some time. Following the establishment of a new 52-week (and indeed, a three year) low on Friday, a bombshell development hit wires this morning and is really causing a stir.

PPS has increased considerably in premarket trading as the company announced that it has sold a pancreatic cancer drug, among other assets, for a cool billion dollars. (>>View PR)

Whenever a major catalytic event such as this transpires, we always like to monitor the situation on the tail end. Hypothetically, a return to its pricing from around this time last year, from this point, would carry a gain of around 100%


Extended Watchlist:
ACNV, GEVO, DRYS,TLOG, SINO, DCIX,

Blue Horseshoe Stocks: NUGT Options Recap & More

Direxion Daily Gold Miners Bull 3X ETF (NUGT)

NUGT has been on a fairly consistent rise for the past few weeks along with gold itself, and we were able to use the continuation of that trend to our extreme advantage yesterday.

We dropped a quick options idea for the NUGT Weekly $9-9.50 Calls into our watchlist, stipulating that we’d need to see a break of the 50DMA. We got what we were looking for, and the potential gains that followed were substantial.

$9 Calls – Range: .56-1.53 – Max Gain: 173%
$9.50 Calls – Range: .30-1.07 – Max Gain: 257%

Chat reminder: Also, we noticed the magnitude of the activity was going to allow for gains to made at higher increments, so we also suggested rolling up to the $10 Calls shortly after the open. Those ended up running 172% from from .25-.68.

We were just mentioning the benefits of our daily traders chats the other day, and here we have a fine example of why reading our premarket reports can be greatly augmented by participating in our in-session chats as well. Again, just send a Skype contact request to ‘stocksumo’ if you wish to join us!  Any of our readers are welcome!


TransEnterix Inc. TRXC – Insider Buying

We noticed a filing for a huge $5.2M insider position increase on TRXC at a price of 1.40, which coincides closely with recent relative lows, and isn’t too far above the stock’s annual low. We’ll be very interested to follow along with this stock after such a vote of confidence from an existing investor.  (>>View Filings)

Added Note: Speaking of insider trading plays, we also wanted to add a quick reminder on the one we submitted yesterday in STON. The stock made modest headway in continuing its established uptrend with a light 8% increase on the day, and will continue to be on our radars moving forward.


Immune Pharmaceuticals, Inc. IMNP

Additionally, we have a reminder to put out on IMNP, which we put on bottom-watch in our report dated December 27th. It took roughly a week of sideways trading for the stock to begin to perk its head up, but yesterday it began to gain some ground so we just wanted to remind readers that we still have this one on our viewscreens.


Extended Watchlist:
AMFE, GIGL, LIGA, GSAT, URRE, BPMX

Get Our FREE Daily Reports!